Iontophoresis is a technique that uses a mild electrical current to push medication or ions through the skin. It’s most commonly known as a treatment for excessive sweating (hyperhidrosis) of the hands and feet, but it’s also used in physical therapy to deliver anti-inflammatory drugs to injured joints and soft tissue. The FDA has approved it as a first-line treatment for palmar and plantar hyperhidrosis, and it’s available both in clinical settings and as a prescription home device.
How Iontophoresis Works
The basic principle is straightforward: like charges repel. A small electrical current is applied to the skin’s surface, and because charged molecules are repelled by the electrode carrying the same charge, they’re driven deeper into the tissue. This process is called electrorepulsion. A second mechanism, called electroosmosis, also contributes. The electrical current creates a flow of water through the skin’s pores, which carries dissolved substances along with it, even ones that don’t carry a strong charge on their own.
The exact contribution of each mechanism is still debated in research, and the precise pathways ions take through the skin haven’t been fully pinpointed. What is well established is the clinical result: iontophoresis reliably delivers therapeutic levels of medication through the skin and, in the case of tap water iontophoresis, temporarily disrupts the sweat glands enough to reduce perspiration dramatically.
Treating Excessive Sweating
This is the most widespread use. During a session, you place your hands or feet in shallow trays filled with tap water while a device sends a low electrical current through the water. Sessions typically last 15 to 40 minutes depending on the device, and the standard protocol starts with three sessions per week until sweating is under control. Once you reach a satisfactory level of dryness, you shift to a maintenance schedule of roughly once per week.
The results can be striking. In a randomized, sham-controlled clinical trial published in the Annals of Dermatology, 92.9% of patients receiving active iontophoresis showed clinical improvement after 10 sessions (compared to 38.5% in the sham group). The average sweat secretion rate dropped by 91.8% in the treatment group. Nearly 79% of treated patients reported meaningful improvement in quality of life. These improvements appeared within two weeks of starting treatment.
Iontophoresis works best for the hands and feet. It can also be used for underarm sweating with special electrode pads, but it’s not generally recommended for the face or scalp because of the technical difficulty and a higher risk of irritation in those areas.
Drug Delivery in Physical Therapy
Beyond hyperhidrosis, iontophoresis is used to push anti-inflammatory medication through the skin directly to an injured area. This approach is common in physical therapy for conditions like tendinitis, bursitis, and joint inflammation. The medication most often delivered this way is a corticosteroid, which reduces swelling and pain in the targeted tissue without requiring an injection.
A typical session involves placing a medicated electrode patch over the treatment area. A low current drives the drug through the skin and into the deeper tissue underneath. Sessions generally take 15 to 30 minutes. The advantage over oral medication is precision: the drug reaches the inflamed area in higher concentrations without circulating through the entire body, which reduces systemic side effects.
What a Session Feels Like
Most people feel a mild tingling or slight itching sensation during the first 30 minutes of current application. This is normal and typically fades as the session continues or shortly after it ends. Some temporary skin redness and mild swelling can occur at the electrode site. These reactions are transient. Research confirms that iontophoresis does not cause permanent skin damage when applied at standard current levels.
The current used is very low. Clinical devices typically operate between 0.1 and 3 milliamps, and practitioners calculate the current density (how much current passes through each square centimeter of skin) to keep it at a safe level, generally no more than 0.5 milliamps per square centimeter. At these settings, the sensation is noticeable but not painful.
Home Devices vs. Clinical Treatment
Several FDA-cleared iontophoresis devices are available for home use by prescription. Brands like Dermadry and Hidrex are designed for a single patient to treat sweating of the hands, feet, and underarms at home. These devices work on the same principle as clinical units and require a physician’s prescription to purchase.
The main trade-off is convenience versus guidance. Home devices let you maintain your treatment schedule without repeated clinic visits, which matters because consistency is critical for results. Missing sessions, especially during the initial phase, can delay improvement. On the other hand, starting treatment under clinical supervision lets a practitioner optimize the current settings and session duration for your specific situation before you transition to home maintenance.
Who Should Avoid Iontophoresis
Iontophoresis is safe for most people, but several situations rule it out. You should not receive iontophoresis if you have a cardiac pacemaker, embedded wires or metal implants near the treatment area, or a history of cardiac arrhythmias. The electrical current, even at low levels, can interfere with these devices or create risks near metal hardware.
Other contraindications include skin lesions or open wounds at the treatment site, areas with impaired sensation (because you can’t gauge whether the current is too strong), and a known allergy to the medication being delivered. Iontophoresis has not been studied during pregnancy and is either avoided entirely or used with extreme caution in pregnant patients. Conditions involving abnormal blood clotting are also a concern if treatment is applied near superficial blood vessels.
Other Medical Applications
Researchers are exploring iontophoresis for drug delivery to the eye. Transscleral iontophoresis can push large protein-based drugs through the outer wall of the eye to reach the retina and choroid, tissues that are otherwise very difficult to treat without direct injection. In animal studies, a 20-minute iontophoresis session delivered meaningful quantities of a drug used to treat abnormal blood vessel growth in the eye. This approach could eventually offer a noninvasive alternative to repeated eye injections for conditions like macular degeneration, though it remains investigational.
The underlying technology is also being studied for delivering pain medications, antibiotics, and other therapeutic agents through the skin in situations where oral dosing is impractical or where targeted delivery would reduce side effects.